Chronic venous insufficiency nursing: assessment, management, and NCLEX tips

Chronic venous insufficiency (CVI) is a condition in which the venous system of the lower extremities fails to return blood effectively to the heart, leading to sustained venous hypertension and progressive tissue damage. It affects an estimated 150 million people worldwide, and venous stasis ulcers — the most severe complication — account for 70–90% of all chronic lower extremity ulcers. For nursing students and practicing nurses, CVI is high-yield because it demands careful wound assessment, precise ABI measurement before initiating treatment, patient education around compression adherence, and the clinical skill to distinguish venous ulcers from arterial and pressure injuries. Missing an arterial component and applying compression to a limb with significant ischemia is one of the most serious errors in wound care practice.

Pathophysiology

Healthy venous return from the lower extremities relies on three mechanisms working together: competent one-way venous valves that prevent retrograde flow, the calf muscle pump that propels blood upward during walking, and the pressure gradient between peripheral veins and the right atrium. When any of these fail, venous blood pools in the lower leg, and sustained venous hypertension results.

Venous valve incompetence is the central defect in CVI. Normally, bicuspid venous valves open to allow blood to flow toward the heart and snap shut to prevent backflow. When valves become incompetent — through congenital weakness, post-thrombotic scarring, or stretching from prolonged venous dilation — blood refluxes downward with each heartbeat and with standing. This reflux sustains elevated ambulatory venous pressures in the lower leg (normally, standing ambulation drops ambulatory venous pressure by ~60–70%; in CVI, this fall is blunted or absent).

Sustained venous hypertension transmits to the capillary level. Elevated capillary hydrostatic pressure drives fluid, proteins, red blood cells, and fibrinogen out of the capillary bed and into the interstitial space. The escaped red blood cells break down, releasing hemosiderin — an iron-rich pigment that deposits in the dermis and produces the characteristic brown staining seen in CVI. Fibrinogen polymerizes into pericapillary fibrin cuffs, and a local inflammatory cascade promotes leukocyte trapping, cytokine release, and endothelial damage. The combined effect is tissue hypoxia, impaired wound healing, and progressive dermal and subcutaneous fibrosis.

Primary vs secondary CVI

Primary CVI stems from intrinsic valve defects — often hereditary — without a prior thrombotic event. Structural weakness of the valve leaflets allows progressive dilation of the vein wall, rendering valves incompetent over time. Family history is a significant risk factor, and CVI has higher prevalence in women, in people who spend prolonged time standing, and in those with obesity.

Secondary CVI develops as a consequence of prior deep vein thrombosis (DVT). This is called post-thrombotic syndrome (PTS). When a DVT organizes and recanalizes, the valve leaflets become scarred and fused, losing their ability to close. PTS develops in 20–50% of patients after proximal DVT, typically within 2 years of the acute event, and is one of the strongest arguments for aggressive DVT prevention and early treatment. Graduated compression stockings worn after acute DVT reduce PTS incidence — a fact that bridges DVT management directly into CVI prevention.

CEAP classification

The CEAP (Clinical-Etiology-Anatomy-Pathophysiology) classification system is the international standard for categorizing CVI severity. Nurses use the Clinical (C) component most directly — it describes the visible and palpable findings and guides treatment intensity.

Clinical presentation

The presenting symptoms of CVI follow a predictable pattern tied to the pathophysiology of venous hypertension. Understanding this pattern is essential for differentiating CVI from arterial insufficiency, lymphedema, and cardiac edema.

Symptoms that worsen with dependency and improve with elevation are the cardinal feature of CVI. Patients describe leg heaviness, aching, fatigue, and a sense of pressure or fullness — typically developing after prolonged standing or sitting and improving markedly when they elevate their legs. This pattern directly reflects venous pooling: upright posture increases venous pressure in the lower leg, elevation reduces it. Arterial insufficiency does the opposite — elevation worsens arterial pain (claudication, rest pain) because it reduces perfusion pressure.

Pitting edema in CVI is bilateral, soft, and pitting — and follows a diurnal pattern, minimal in the morning and most pronounced at the end of the day after prolonged upright activity. The edema is distributed in the ankle and lower leg (gaiter area) rather than the foot dorsum (which raises concern for lymphedema) or the entire lower extremity (which raises concern for proximal venous obstruction or systemic causes).

Skin changes

The skin findings in CVI are produced by chronic inflammation, hemosiderin deposition, and fibrosis. Their progression generally mirrors CEAP staging.

Hemosiderin deposits appear as brown or rust-colored skin staining on the medial ankle and lower leg. This is one of the most recognizable and NCLEX-tested signs of CVI. The color is produced by iron from degraded red blood cells that escaped from the capillary bed. The staining is permanent even if CVI is treated — it does not reverse.

Venous stasis dermatitis (stasis eczema) produces erythema, scaling, weeping, and pruritus on the medial lower leg. The skin is fragile and easily traumatized. Secondary bacterial infection (cellulitis) is a significant risk. Topical corticosteroids are used for active inflammation, but prolonged use thins already-fragile skin.

Lipodermatosclerosis is a fibrotic, inflammatory process in the dermis and subcutaneous fat of the lower leg. The leg takes on a classic “inverted champagne bottle” shape — indurated (woody, hard) in the lower third and swollen above, because fibrosis tethers the skin while edema accumulates proximally. This finding indicates advanced CVI (CEAP C4b) and is associated with higher ulcer risk.

Atrophie blanche refers to smooth, white, avascular scars on the medial ankle — areas of skin where capillary thrombosis has produced ischemic scarring. These areas are pain-sensitive and prone to ulceration with minor trauma.

Venous stasis ulcers

Venous ulcers are the most serious complication of CVI, representing CEAP C6. Their characteristics are clinically distinct and must be recognized to direct appropriate wound care and differentiate them from arterial ulcers and pressure injuries.

• Location: Medial malleolus and the gaiter area (lower leg between ankle and mid-calf) — the highest-pressure zone in the venous system
• Shape: Irregular borders, often described as “ragged” or “shallow crater”
• Wound bed: Granulation tissue (beefy-red, moist) — venous ulcers have adequate local blood supply for healing; the problem is venous pressure, not ischemia
• Exudate: Moderate to heavy — the high venous pressure drives fluid out of the wound bed
• Pain: Minimal to moderate; significantly less painful than arterial ulcers. Patients often report the leg aches more than the wound itself hurts
• Surrounding skin: Hemosiderin staining, lipodermatosclerosis, stasis dermatitis, edema
• Healing: Slow without compression; respond well to compression therapy, which reduces venous pressure and promotes granulation

Comparing wound types

One of the highest-yield clinical skills in wound assessment is differentiating venous, arterial, and pressure injuries. This table is essential for NCLEX and for clinical practice. See also the wound assessment nursing reference and the pressure injury nursing reference.

The critical clinical rule: never apply compression before checking ABI. An arterial ulcer treated with compression can progress to gangrene and limb loss. For mixed arterial-venous disease (which is common), ABI guides whether any compression is safe and at what level.

Diagnosis

Clinical diagnosis is the starting point. History and physical examination together provide the foundation — the symptom pattern (dependent worsening, elevation relief), bilateral edema, hemosiderin staining, varicose veins, and wound characteristics at the medial malleolus are sufficient for a clinical diagnosis of CVI in most patients.

Duplex ultrasound is the gold standard for confirming CVI and characterizing the anatomical distribution of valve incompetence. The study combines B-mode imaging (structural anatomy of the veins) with Doppler flow assessment. Venous reflux is defined as retrograde flow lasting >0.5 seconds in superficial veins and >1 second in deep veins following Valsalva or manual compression-release maneuver. Duplex ultrasound also identifies deep venous obstruction from post-thrombotic scarring and distinguishes superficial from deep system incompetence — information that guides whether surgical intervention on superficial veins would reduce venous hypertension.

Ankle-brachial index (ABI) must be measured before initiating compression therapy. This is one of the most important nursing safety checks in wound care. The ABI compares the systolic blood pressure at the ankle to the brachial systolic pressure. ABI ≥0.8 indicates adequate arterial perfusion — compression is safe. ABI 0.6–0.79 represents moderate arterial disease — modified compression (reduced pressure, e.g., 20–30 mmHg) may be used with vascular specialist input. ABI <0.6 is an absolute contraindication to compression — arterial flow is insufficient to withstand external pressure, and compression would precipitate ischemia, ulceration, and potential limb loss. See the peripheral arterial disease (PAD) nursing reference for ABI measurement technique.

Photoplethysmography (PPG) and air plethysmography provide non-invasive functional assessment of venous reflux and venous filling time when duplex is unavailable or as a complement to it. These are used more commonly in specialized vascular or wound care clinics.

Nursing assessment

A structured CVI assessment covers five domains: symptoms, limb appearance, skin integrity, wound characteristics (if ulcer present), and vascular status.

Symptom history: Onset, duration, severity of leg heaviness, aching, and swelling. Postural pattern — does it worsen with standing? Improve with elevation? History of DVT, thrombophilia, family history of varicose veins or CVI, prior venous procedures.

Limb assessment: Bilateral limb circumference measured at a consistent anatomical landmark (e.g., 10 cm above medial malleolus) at each visit. Assess for pitting edema — grade 1 (slight, 2 mm, rebounds rapidly) through grade 4 (deep, >8 mm, rebounds slowly). Note location and distribution of varicose veins.

Skin assessment: Hemosiderin staining extent and distribution. Presence of stasis dermatitis (erythema, scaling, weeping). Lipodermatosclerosis (document as indurated area, measure if possible). Atrophie blanche. Skin integrity breaks — even minor abrasions in CVI skin can become portal for infection or ulcer formation.

Wound assessment (if CEAP C5–C6): Location, dimensions (length × width × depth), wound bed (granulation, fibrin slough, necrotic tissue), exudate type and amount, wound edges, periwound skin condition. Document using a validated tool (e.g., PUSH tool or wound measurement guide per facility protocol). Photograph with consent at each wound clinic visit.

Vascular assessment: Palpate dorsalis pedis and posterior tibial pulses bilaterally. ABI measurement before any compression. Signs of infection: cellulitis (spreading erythema, warmth, fever), wound with purulent exudate, increasing pain (infection in venous ulcers can be subtle — foul odor and increased exudate are early signs). Signs of new DVT: sudden increase in unilateral swelling, calf tenderness — escalate to provider immediately.

Management

Compression therapy

Compression is the cornerstone of CVI treatment. External compression reduces the diameter of superficial and deep veins, lowers ambulatory venous pressure, reduces edema, and promotes venous return. Without compression, other interventions — elevation, exercise, wound dressings — provide only partial benefit.

Positioning and exercise

Leg elevation above heart level reduces venous pressure mechanically. The recommendation is 30 minutes of elevation, 3–4 times per day. For significant edema or active ulcers, elevation during sleep (feet slightly higher than the head) provides sustained overnight pressure reduction. Elevating the foot of the bed by 15–20 cm is a practical strategy. Chair elevation (footstool to chest height) is insufficient — the leg must be above the level of the right atrium.

Walking and calf muscle pump activation are as therapeutically important as compression. The calf muscle pump generates 60–80% of venous return in the lower extremity by compressing the deep venous sinuses of the soleus muscle with each contraction. Calf muscle pump dysfunction — from immobility, obesity, neurological conditions, or ankle stiffness — is a major driver of CVI progression. Structured walking programs, ankle flexion-extension exercises for patients who cannot walk, and water aerobics (the hydrostatic pressure of water acts similarly to compression) all improve venous return. Physical activity should be encouraged unless wound condition or co-morbidities limit it.

Wound care

For active venous ulcers (CEAP C6), wound management focuses on creating an optimal healing environment while compression reduces the underlying venous hypertension.

Cleansing: Gentle irrigation with normal saline or potable tap water at each dressing change. Avoid cytotoxic agents (povidone-iodine, hydrogen peroxide, Dakin’s solution) on granulating wound beds — these impair wound healing. Reserve antimicrobial irrigation for clinically infected wounds per provider order.

Dressing selection: The wound bed should be kept moist without maceration of periwound skin. Moderate-to-heavy exudate from venous ulcers typically requires highly absorbent dressings:

• Foam dressings — manage moderate-to-heavy exudate; non-adherent to wound bed; comfortable under compression
• Alginate dressings — derived from seaweed; highly absorbent; useful for heavily exudating wounds or those with some depth
• Hydrocolloid dressings — appropriate for wounds with low-to-moderate exudate; create moist healing environment; can stay in place 3–5 days
• Antimicrobial dressings (silver-impregnated, cadexomer iodine) — for wounds showing signs of infection or critical colonization

Periwound skin protection: Moisture-associated skin damage from exudate is a secondary injury risk. Apply zinc oxide paste, petrolatum, or barrier cream to periwound skin before applying absorbent dressings.

Pharmacological management

Pentoxifylline (Trental) is the best-evidenced pharmacological adjunct for venous ulcer healing. A xanthine derivative, it improves red blood cell deformability and reduces leukocyte adhesion — both of which are impaired in the microcirculation of CVI. Used at 400 mg three times daily in combination with compression, it has been shown in meta-analyses to increase ulcer healing rates compared to compression alone. Nursing implication: GI side effects (nausea, dyspepsia) are common; take with food.

Horse chestnut seed extract (HCSE, aescin) is a venotonic used in European practice with moderate evidence for reducing CVI symptoms (edema, heaviness, pain). The active compound, aescin, inhibits lysosomal enzymes involved in proteoglycan degradation in the vein wall. It is available over the counter in the US and used as an adjunct in patients who cannot tolerate or afford compression.

Aspirin (300 mg daily) has been studied as an adjunct for venous ulcer healing, with some evidence of modest benefit, likely through platelet aggregation inhibition and anti-inflammatory effects. It is not universally recommended but may be considered in patients without contraindications.

Diuretics are generally not recommended for CVI edema — they deplete intravascular volume without reducing venous hypertension, and they can precipitate or worsen acute kidney injury. If diuretics are prescribed, it is typically because the patient has a concurrent cardiac or renal cause of edema, not purely CVI.

Surgical and interventional options

Endovenous laser ablation (EVLA) and radiofrequency ablation (RFA) use heat to close incompetent superficial veins (typically the great saphenous vein) from within. These are the current first-line interventional options — minimally invasive, performed under local anesthesia, with high success rates and low complication profiles. Eliminating superficial reflux reduces the overall venous pressure burden and, in patients with combined superficial and deep disease, can substantially improve symptoms and ulcer healing.

Sclerotherapy involves injecting a chemical irritant (e.g., sodium tetradecyl sulfate, polidocanol) into varicose veins or incompetent perforator veins to induce fibrosis and closure. Used for smaller varicosities and as adjunctive treatment after EVLA/RFA.

Open surgery (high ligation and stripping) has been largely replaced by EVLA and RFA, but remains relevant for complex or recurrent cases.

Deep venous reconstruction (venous bypass, valve transplantation, or stenting for post-thrombotic obstruction) is reserved for severe refractory cases with confirmed deep venous obstruction or reflux not amenable to superficial ablation. Performed at specialized vascular centers.

Monitoring and safety priorities

Monitor for cellulitis. The skin of CVI patients is a compromised barrier — edematous, inflamed, and prone to breakdown. Cellulitis (spreading erythema, warmth, induration, systemic fever) requires prompt escalation and antibiotic therapy. Group A Streptococcus is the most common pathogen. Distinguish cellulitis from stasis dermatitis, which can look similar but lacks systemic features and does not spread rapidly.

Monitor for new DVT. Post-thrombotic syndrome is a consequence of prior DVT, and the same risk factors that caused the original DVT (immobility, hypercoagulability) remain active. Sudden increase in unilateral swelling or calf tenderness in a CVI patient should prompt DVT evaluation — compression is the same treatment for both, but anticoagulation is specifically indicated for DVT and not for CVI.

Reassess ABI periodically. Patients with CVI who develop new symptoms of arterial insufficiency (rest pain, non-healing wound on toe, calf claudication) need repeat ABI measurement before continuing compression. The vascular profile can change — particularly in diabetic patients or those with progressive atherosclerosis.

Compression adherence at every visit. Studies consistently show that poor adherence to compression is the primary reason venous ulcers fail to heal and recur after healing. At every clinical contact, ask directly whether the patient is wearing compression stockings, how many hours per day, and what barriers exist. Common barriers include difficulty applying stockings (arthritic hands, obesity, poor dexterity), discomfort, cost, and aesthetics. Stocking applicator devices, zippered stocking products, and Velcro-closure wraps are adaptations that significantly improve adherence.

NCLEX tips

1. ABI threshold for compression is ≥0.8. An ABI <0.6 is an absolute contraindication to standard compression. ABI 0.6–0.79 requires specialist input and modified compression. This is one of the most frequently tested CVI facts on NCLEX — choosing to apply compression without checking ABI is always the wrong answer.

2. Venous ulcers are at the medial malleolus. Arterial ulcers are at the toes, lateral malleolus, and pressure points on an ischemic limb. Location is the quickest differentiating feature in NCLEX questions.

3. Hemosiderin deposits = brown skin staining = CVI. When a question describes brown or rust-colored skin discoloration on the medial lower leg, think CVI and hemosiderin from degraded RBCs. The staining is permanent.

4. Lipodermatosclerosis = woody induration of the lower leg. This fibrotic change indicates advanced CVI (CEAP C4b). The leg takes on an inverted champagne bottle shape — hard and indurated distally, with edema above.

5. CEAP C6 = active venous ulcer (highest clinical stage). If an NCLEX question asks you to identify the most severe stage of CVI, the answer is C6. C5 is a healed ulcer; C6 is open.

6. Venous ulcer pain is minimal to moderate. Arterial ulcer pain is severe, especially at rest (rest pain = ischemia, limb threat). If an NCLEX question describes a patient with severe rest pain and an ulcer, think arterial — not venous.

7. Elevation above heart level relieves venous hypertension. Elevating the legs above the right atrium reduces hydrostatic pressure in the lower leg veins and improves venous return. This is therapeutic for CVI; it worsens arterial insufficiency by reducing perfusion pressure — another differentiating fact.

8. Post-thrombotic syndrome (PTS) = secondary CVI from DVT-damaged valves. Any question that links prior DVT to later development of chronic edema, skin changes, or ulcers at the medial malleolus is describing PTS — a form of secondary CVI. Reinforces the importance of DVT prevention.

9. Duplex ultrasound is the gold standard for venous reflux diagnosis. It documents valve incompetence and guides intervention decisions. Clinical diagnosis is appropriate for initiating conservative management, but duplex is needed before surgical or ablative intervention.

10. Compression is the cornerstone of CVI treatment — adherence is the #1 barrier to ulcer healing. NCLEX often tests what the nurse should do when a patient returns with a non-healing venous ulcer despite good wound care. Assessing compression adherence is the priority nursing action.

11. Calf muscle pump dysfunction worsens venous return — walking improves it. The calf muscle pump generates the majority of venous return from the lower extremity. Immobility impairs it; structured walking activates it. Encouraging ambulation in CVI patients is a nursing priority, not a risk.

12. Venous ulcers have irregular borders and granulation tissue; arterial ulcers have punched-out borders and minimal granulation. The wound bed appearance is high-yield for NCLEX wound assessment questions. Granulation tissue (beefy-red, moist, bumpy) indicates adequate local blood supply — consistent with venous ulcers. Necrosis or eschar in an ulcer on the toes indicates ischemia — consistent with arterial insufficiency.

Internal links

• Deep vein thrombosis is the most common cause of secondary CVI — see the DVT nursing reference for Virchow’s triad, Wells score, and anticoagulation management.
• ABI measurement technique and interpretation are covered in the peripheral arterial disease (PAD) nursing reference.
• Wound bed assessment principles, dressing selection, and documentation apply across wound types — see the wound assessment nursing reference.
• Differentiating venous ulcers from pressure injuries requires understanding staging and tissue depth — see the pressure injury nursing reference.
• Fractures can cause prolonged immobility, which accelerates CVI progression — see the fractures nursing reference for immobility complications.
• Fluid management decisions in patients with CVI and co-morbid heart failure require understanding of the heart failure nursing reference.
• Pulmonary embolism is the downstream consequence of DVT — which causes secondary CVI — see the pulmonary embolism nursing reference.

Summary

Chronic venous insufficiency is a progressive condition driven by venous valve incompetence and sustained venous hypertension. Its clinical spectrum runs from asymptomatic telangiectasias (CEAP C1) to active venous ulcers at the medial malleolus (CEAP C6), with hemosiderin deposits, lipodermatosclerosis, and pitting edema marking the intervening stages. ABI measurement before initiating compression is the most critical safety priority — compression applied to a limb with ABI <0.6 can cause ischemia and limb loss. Graduated compression is the cornerstone of treatment and ulcer healing; adherence is the primary clinical challenge. Secondary CVI from post-thrombotic syndrome reinforces why DVT prevention and early treatment matter. For NCLEX, the highest-yield facts are ABI thresholds, ulcer location (medial malleolus), hemosiderin staining as the classic skin sign, CEAP staging, and the directional difference in how elevation affects venous versus arterial pain.